Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
AFC-HD AMS Life Science Co., Ltd. (2927.T)
Shizuoka, JP
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.71% | +0.00% | -2.08% | -6.62% | -2.53% | -5.36% | -1.40% | +9.57% | -10.18% | -1.97% | -44.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+8.2% ★ Q1'26: -1.5% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+15.8% ★ Q1'26: -36.2% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+0.9% Q1'26: -21.1% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+7.4% Q1'26: +5.8% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+5.7% Q1'26: +4.2% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%0.0% ★ Q1'26: +3.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×6.35× Q1'26: 7.09× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Aug 2020 actual |
Aug 2021 actual |
Aug 2022 actual |
|---|---|---|---|
| Revenue |
15.82B
est: 15.50B (+2.1%)
|
22.37B
est: 18.50B (+20.9%)
|
23.00B
est: 19.00B (+21.0%)
|
| EBITDA |
1.55B
est: 1.70B (-8.9%)
|
2.86B
est: 2.03B (+41.0%)
|
2.30B
est: 2.08B (+10.5%)
|
| EBIT |
1.04B
est: 1.11B (-6.5%)
|
2.21B
est: 1.32B (+66.8%)
|
1.29B
est: 1.36B (-4.9%)
|
| Net Income |
676.68M
est: 600.70M (+12.6%)
|
1.50B
est: 1.29B (+15.9%)
|
735.35M
est: 1.32B (-44.3%)
|
| SGA |
3.34B
est: 4.16B (-19.6%)
|
4.42B
est: 4.96B (-11.0%)
|
7.26B
est: 5.10B (+42.5%)
|
| EPS |
48.12
est: 42.70 (+12.7%)
|
107.12
est: 91.70 (+16.8%)
|
52.33
est: 93.90 (-44.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.00% | 43.6K | 0.39% |
| 2 | Avantis International Small Cap Value ETF AVDV | 0.00% | 83.5K | 0.36% |
| 3 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 54.2K | 0.22% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 37.0K | 0.28% |
| 5 | Avantis International Equity ETF AVDE | 0.00% | 4.3K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Naoya Unno | GM of Technical Development Division & Director | — | male |
| Nobue Hamabe | Accounting Manager & Director | — | female |
| Shigenori Fukuchi | Senior MD, Head of Manufacturing & Director | — | male |
| Shigeo Minakata | Head of the Chairman's Office & Director | — | male |
| Yasuhiro Matsunaga | President & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2927.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
